The actin-bundling protein L-plastin-A double-edged sword: Beneficial for the immune response, maleficent in cancer

Int Rev Cell Mol Biol. 2020:355:109-154. doi: 10.1016/bs.ircmb.2020.05.004. Epub 2020 Jul 4.

Abstract

The dynamic organization of the actin cytoskeleton into bundles and networks is orchestrated by a large variety of actin-binding proteins. Among them, the actin-bundling protein L-plastin is normally expressed in hematopoietic cells, where it is involved in the immune response. However, L-plastin is also often ectopically expressed in malignant cancer cells of non-hematopoietic origin and is even considered as a marker for cancer progression. Post-translational modification modulates L-plastin activity. In particular, L-plastin Ser5 phosphorylation has been shown to be important for the immune response in leukocytes as well as for invasion and metastasis formation of carcinoma cells. This chapter discusses the physiological and pathological role of L-plastin with a special focus on the importance of L-plastin Ser5 phosphorylation for the protein functions. The potential use of Ser5 phosphorylated L-plastin as a biomarker and/or therapeutic target will be evoked.

Keywords: Actin-binding protein; Cancer; Fimbrin; Immune response; Invasion; L-plastin; LCP1; Phosphorylation; Post-translational modification; Thiol oxidation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actin Cytoskeleton / metabolism
  • Humans
  • Immunity*
  • Microfilament Proteins / immunology
  • Microfilament Proteins / metabolism*
  • Neoplasms / metabolism*
  • Phosphorylation
  • Protein Processing, Post-Translational
  • Signal Transduction

Substances

  • LCP1 protein, human
  • Microfilament Proteins